跳至主要内容
临床试验/NCT00584688
NCT00584688终止2 期

A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

University of South Florida2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2007年2月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
24
试验地点
2
主要终点
To determine efficacy of seroquel in anorexia nervosa

研究概览

简要总结

Research studies raise the possibility that medications such as quetiapine may improve mood or reduce obsessions in people with anorexia nervosa and may even help to normalize appetite. The medication quetiapine also known as seroquel works by activating certain systems in the brain, such as ones known as dopamine and serotonin chemical systems in the brain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be aged 18-65
  • Must be at least 15% below ideal body weight

排除标准

  • Allergy to quetiapine
  • Diagnosis of schizophrenia

结局指标

主要结局

To determine efficacy of seroquel in anorexia nervosa

时间窗: 8 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验